How does eviQ support cancer treatment in NSW?
eviQ is used by clinicians, patients and policy makers to support best practice and achieve improved cancer outcomes.
What is the purpose of eviQ?
eviQ aims to ensure people with cancer receive the right treatment, at the right time, in the right dose.
It takes research data generated across the world, and brings it into one online portal so that it can be used by all Australian clinicians – metropolitan, rural and regional.
What is the goal of eviQ?
The goal of eviQ is to improve outcomes for people with cancer by reducing variation in treatment.
The online portal provides treatment guidelines, allowing health professionals to provide consistent treatments across Australia.
How does eviQ work with health professionals?
eviQ assists practitioners in the specifics of treatment delivery after a treatment decision has been made.
By standardising cancer treatments, eviQ reduces clinical variation and improves the quality of care.
While protocols help to standardise care, they are not meant to be restrictive, and variations should be used based on clinical judgment and the needs of individual patients.
What is on eviQ?
There are seven key content areas represented on the eviQ website:
- Medical Oncology
- Haematology
- Radiation Oncology
- Cancer Genetics
- Bone Marrow Transplant
- Nursing content
- Patient information.
Chemotherapy treatment protocols cover information including:
- the type of patient population that should be treated with a protocol
- drug dosing
- how to prescribe the medication in the safe way
- toxicities and side effects
- how dose modifications should be made for that particular type of tumour.
Each protocol incorporates a patient-focused information sheet, developed in accordance with the medical content and reviewed by a health literacy advisor.
Visit eviQ to explore the full range of content.
How is eviQ content created?
Protocols are developed following a rigorous literature search and appraisal process, based on the highest quality and most comprehensive evidence available.
Reference Committees consisting of multidisciplinary clinical experts meet at regular, formal face-to-face meetings to review the information.
Protocols are approved and published on the site only when consensus is reached. Content is then reviewed every one, two or five years.